NP Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers (NCT04679493) | NP Therapeutics | 2020-12-17 |
Track NP Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.